Metuchen Pharmaceuticals, LLC

New Filing
CIK: 0001799256·Pharmaceuticals·DELAWARE·Filed: Jan 9, 2020
Total Offering

$3,500,000

Amount Sold

$3,132,739

Investors

30

First Sale

Sep 16, 2019

Offering Details

Type
Equity, Option to Acquire
Exemptions
Rule 506(b)
Entity Type
Limited Liability Company
Year Incorporated
2016
Non-Accredited Investors
No

Related Persons

NameRole
John D. Shulman
Related Person
Greg Ford
Related Person
Keith Lavan
Related Person

Company

Metuchen Pharmaceuticals, LLC

200 US HIGHWAY 9

MANALAPAN, NJ, 07726

848-233-5568

SEC Filing

0001799256-20-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Metuchen Pharmaceuticals, LLC Form D Filing — $3,500,000 | FilingFlow